Agios Pharmaceuticals, Inc(NASDAQ:AGIO) 
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers TIBSOVO (ivosidenib), an oral targeted inhibitor for treating adult patients with relapsed or refracto...
Website: http://www.agios.com
Founded: 2008
Full Time Employees: 536
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 27.22
H 27.86
L 25.26
C 25.76
V 1,192,473
10EMA 25.76
20EMA 25.76
60EMA 25.76
120EMA 25.76
250EMA 25.76